5Suppliers
6Customers
2Debt Items
20Related Chains

Corcept Therapeutics Incorporated Suppliers

TickerNameConfidenceEvidence
BRK-B Berkshire Hathaway Inc. 80% Reciprocal relationship from BRK-B graph: Our other service businesses franchise and service a network of quick service restaurants (Dairy Queen), lease transportation equipment (XTRA) and furniture …
ORANY ORANY 72% mentation and the obligation to investigate and correct any deviations from cGMP. Manufacturers and other entities involved in the manufacture and distribution of approved products are required to re…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from CORT graph: mentation and the obligation to investigate and correct any deviations from cGMP. Manufacturers and other entities i…
XERS Xeris Biopharma Holdings, Inc. 72% ol synthesis inhibitor osilodrostat to treat patients with Cushing’s disease, which approval was broadened in April 2025 to include adult patients with any etiology of hypercortisolism. 24 In 2021, X…
XERS Xeris Biopharma Holdings, Inc. 72% Reciprocal relationship from XERS graph: Reciprocal relationship from CORT graph: Reciprocal relationship from XERS graph: Reciprocal relationship from CORT graph: Reciprocal relationship from XERS g…

Corcept Therapeutics Incorporated Customers

TickerNameConfidenceEvidence
OPTIME-CARE-INC OPTIME-CARE-INC 85% Antitrust Litigation On June 13, 2024, Teva filed a complaint in the Northern District of California, captioned Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc., et al. (N.D. Cal.), Case …
ORANY ORANY 72% mentation and the obligation to investigate and correct any deviations from cGMP. Manufacturers and other entities involved in the manufacture and distribution of approved products are required to re…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from CORT graph: mentation and the obligation to investigate and correct any deviations from cGMP. Manufacturers and other entities i…
XERS Xeris Biopharma Holdings, Inc. 72% Reciprocal relationship from XERS graph: duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC (collectively "SHL"). SHL produces device…
XERS Xeris Biopharma Holdings, Inc. 72% range of disorders, including central serous retinopathy, post-traumatic stress disorder, anxiety, alcoholism, cocaine addiction, Alzheimer’s disease, ALS, hypercortisolism, metabolic syndrome, ather…
HEALTH-CARE-SERVICE-CORPORATION HEALTH-CARE-SERVICE-CORPORATION 70% several named plaintiffs filed a complaint against Corcept in the Alameda County Superior Court for the State of California, captioned, Aetna Inc., Health Care Service Corporation, Humana Inc. and Mo…

Corcept Therapeutics Incorporated Debt Obligations

InstrumentDescriptionConfidenceEvidence
CORT-DEBT Debt stack $9.6M 90% Market cache reports total debt of $9.6M.
CORT-DEBT-8797 Xbrl Convertible 90% xbrl convertible detail from xbrl 2011-12-31.

Corcept Therapeutics Incorporated Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Corcept Therapeutics Incorporated.

Corcept Therapeutics Incorporated Ownership

HolderNameConfidenceEvidence
CORT-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 357 tracked holders.

Corcept Therapeutics Incorporated Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BRK-B Berkshire Hathaway Inc. 100.00 1 ['supplier']
ORANY ORANGE 100.00 1 ['customer', 'supplier']
AMZE Amaze Holdings, Inc. 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
D Dominion Energy, Inc. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
ESS Essex Property Trust, Inc. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
FENC Fennec Pharmaceuticals Inc. 50.00 2
EQR Equity Residential 50.00 2
CNOB ConnectOne Bancorp, Inc. 50.00 2
DWTX Dogwood Therapeutics, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
RYAN Ryan Specialty Holdings, Inc. 50.00 2
ED Consolidated Edison, Inc. 50.00 2
SCNX Scienture Holdings, Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2